Document:

Exhibit 10.3

 

FIVE STAR QUALITY CARE, INC.

 

Summary of Director Compensation

 

The following is a summary of the currently effective compensation of the directors of Five Star Quality Care, Inc. (the “Company”) for services as directors, which is subject to modification at any time by the Board of Directors.

	
             
 	
            •
 	
            Each independent director receives an annual fee of $25,000, plus a fee of $500 for each meeting attended.  Up to two $500 fees are payable if a board meeting and one or more board committee meetings are held on the same date.
 

	
             
 	
            •
 	
            The chairpersons of the quality of care committee, the audit committee, the compensation committee and the nominating and governance committee, each of whom is an independent director, receive an additional annual fee of $12,500, $7,500, $3,500 and $3,500, respectively.
 

	
             
 	
            •
 	
            Each director is entitled to receive a grant of 4,000 of the Company’s shares of common stock on the date of the first board meeting following each annual meeting of shareholders (or, for directors who are first elected or appointed at other times, on the day of the first board meeting attended).
 

	
             
 	
            •
 	
            The Company generally reimburses all directors for travel expenses incurred in connection with their duties as directors.Exhibit 10.1

LOJACK CORPORATION

 

Summary of Board Compensation

 

The following is a summary of the currently effective compensation of the board of directors of LoJack Corporation (the “Company”) for services as directors, which is subject to modification at any time by the Board of Directors.

	
             
 	
            •
 	
            An annual cash retainer of $20,000 per director
 

	
             
 	
            •
 	
            Audit Committee Chair compensation of $10,000 per year
 

	
             
 	
            •
 	
            Compensation Committee Chair compensation of $7,500 per year
 

	
             
 	
            •
 	
            Nominating / Governance Chair compensation of $5,000 per year
 

	
             
 	
            •
 	
            Lead Director compensation of $5,000 per year
 

	
             
 	
            •
 	
            Board Meeting fee of $1,500 per meeting  ($750 per telephone meeting or telephone participation in a meeting.  No fee for brief telephone meetings.)
 

	
             
 	
            •
 	
            Committee Meeting fee of $1,000 per meeting ($750 per telephone meeting or telephone participation in a meeting.  No fee for brief telephone meetings.)
 

	
             
 	
            •
 	
            An annual grant (on the third business day after the annual meeting) of $80,000 (rounded to the nearest whole number of shares) in value of restricted stock subject to forfeiture and restrictions on transfer, such restrictions to lapse after two years.  
 

Annual restricted share grants and compensation shall be prorated for new directors taking office between annual shareholder meeting dates.EXHIBIT 4.1

 

THIS WARRANT HAS BEEN, AND THE SHARES OF COMMON STOCK WHICH MAY BE RECEIVED PURSUANT TO THE EXERCISE OF THIS WARRANT WILL BE, ACQUIRED SOLELY FOR INVESTMENT AND NOT WITH A VIEW TO, OR FOR RESALE IN CONNECTION WITH, ANY DISTRIBUTION THEREOF.   NEITHER THIS WARRANT NOR SUCH SHARES (TOGETHER, THE “SECURITIES”) HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR QUALIFIED UNDER ANY STATE SECURITIES LAWS.  SUCH SECURITIES MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR QUALIFICATION OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH DISPOSITION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE ACT AND ANY REGISTRATION OR QUALIFICATION REQUIREMENTS
UNDER APPLICABLE STATE SECURITIES LAWS.

	
            No. 2006-
 	
            Issued:  
 	
            , 2006
 

WARRANT TO PURCHASE COMMON STOCK

Expires , 2009

This warrant (this “Warrant”) certifies that, for good and valuable consideration, , an individual residing at  (the “Holder) is entitled to purchase from Protocall Technologies Incorporated, a Nevada corporation (the “Company”)           () fully paid and nonassessable shares of Common Stock, par value $0.001 per share (“Common Stock”), of the Company (as adjusted pursuant to Section 3) (the “Warrant Shares”)  (  ) (as adjusted pursuant to Section 3) (the “Exercise
Price”), upon the terms and subject to the conditions hereinafter set forth.

	
            1.
 	
            Exercise; Payment.
 

(a)         Exercise Period.  This Warrant may be exercised in whole or part by the Holder during the term (as set forth in Section 10) and in compliance with the provisions of this Warrant at any time after the date of issuance set forth above (the “Warrant Date”), by the surrender of this Warrant (with the notice of exercise form attached hereto as Exhibit A (the “Notice of Exercise”) or the notice of cashless exercise form attached hereto as Exhibit B (the “Notice of Cashless Exercise”) duly executed) at the principal office of the Company.  If
this Warrant shall have been exercised in part, the Company shall, at the time of delivery of the certificate or certificates representing Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased shares of Common Stock called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant, or at the request of the Holder, appropriate notation may be made on this Warrant and the same returned to the Holder.

(b)         Exercise.  Upon exercise of this Warrant, the Holder shall pay to the Company an amount equal to the product of (x) the Exercise Price multiplied by (y) the total number of Warrant Shares purchased pursuant to this Warrant, by wire transfer or cashier’s check payable to the order of the Company.  The Holder shall be deemed to have become the holder of record of, and shall be treated for all purposes as the record holder of, the Warrant Shares represented thereby (and such Warrant Shares shall be deemed to have been issued) immediately prior to the close of 

 

 

business on the date upon which this Warrant is exercised.  Notwithstanding the foregoing, the Holder shall have the right (the “Right of Cashless Exercise”), at its election, in lieu of delivering the Exercise Price in cash, to instruct the Company in the Notice of Cashless Exercise to retain, in payment of the Exercise Price, that number of Warrant Shares that have an aggregate Fair Market Value (as defined below) equal to the Exercise Price (the “Payment Shares”) from the number of Warrant Shares as to which this Warrant is then being exercised.  In the event the Holder elects to exercise its Right of Cashless Exercise, the Holder shall surrender this Warrant pursuant to the terms and conditions herein, together with the Notice of Exercise attached hereto, duly executed, and the Payment
Shares shall be deducted from the Warrant Shares to be delivered to the Holder.  “Fair Market Value” means, as of any date, (i) if Warrant Shares are listed on a national securities exchange, the average of the closing sale price per share therefor on the securities exchange on which the greatest average volume of such shares are traded over the last ten (10) trading days before such date, (ii) if such shares are listed on The Nasdaq National Market but not on any national securities exchange, the average of the average of the closing bid and asked prices per share therefor over The Nasdaq National Market, for the last ten (10) trading days before such date, (iii) if such shares are not listed on either a national securities exchange or The Nasdaq National Market, the average of the closing bid and asked prices per share therefor in the over the counter market over the last twenty (20) trading days before such date or, (iv) if
no such sales or bid and asked prices are available, the fair market value of the Company per share of outstanding Common Stock as of such date, as determined in good faith by the Board of Directors of the Company.

(c)         Stock Certificates.  In the event of the exercise of this Warrant, certificates for the Warrant Shares so purchased shall be delivered to the Holder promptly after exercise but in no event more than ten (10) business days after such exercise.

2.           Stock Fully Paid; Reservation of Shares.  All of the Warrant Shares issuable upon the exercise of this Warrant will, upon issuance in accordance with the terms of this Warrant, be fully paid and nonassessable, and free from all preemptive rights, rights of first refusal or first offer, taxes, liens and charges with respect to the issuance thereof.  During the period within which the rights represented by this Warrant may be exercised, the Company shall at all times have authorized and reserved for issuance a sufficient number of shares of its Common Stock to provide for the exercise of this Warrant.

3.           Adjustment of Exercise Price and Number of Shares.  The number and kind of Warrant Shares purchasable upon the exercise of this Warrant and the Exercise Price payable therefor shall be subject to adjustment from time to time upon the occurrence of certain events, as follows:

(a)         Reclassification, Consolidation or Reorganization.  In case of any reclassification of the Common Stock (other than a change in par value, or as a result of a subdivision or combination), or in case of any consolidation or merger of the Company with or into another corporation (other than a Change of Control, as defined below) (any of which is a “Reorganization Transaction”), the Company, or such successor corporation as the case may be, shall execute a new warrant, providing that the Holder shall have the right to exercise such new warrant, and procure upon such exercise and payment of the same aggregate Exercise Price, in lieu of the Warrant Shares theretofore issuable upon exercise of this Warrant, the kind and amount of shares of stock, other 

 

2

 

 

securities, money and property as would be payable for the Warrant Shares issuable upon exercise of this Warrant as if such Warrant Shares were outstanding immediately prior to the consummation of the Reorganization Transaction.  For purposes of this Warrant, the term “Change of Control” shall mean (i) any acquisition of the Company by means of merger, acquisition, or other form of corporate reorganization in which outstanding shares of the Company are exchanged for securities or other consideration issued, or caused to be issued, by the acquiring corporation or its subsidiary or parent (other than a reincorporation transaction or change of domicile) and pursuant to which the holders of the outstanding voting securities of the Company immediately prior to such consolidation, merger or other transaction fail to hold equity securities representing a
majority of the voting power of the Company or surviving entity immediately following such consolidation, merger or other transaction (excluding voting securities of the acquiring corporation held by such holders prior to such transaction) or (ii) a sale of all or substantially all of the assets of the Company.

(b)         Stock Splits, Dividends and Combinations.  In the event that the Company shall at any time subdivide the outstanding shares of Common Stock, or shall issue a stock dividend on its outstanding shares of Common Stock, the number of Warrant Shares issuable upon exercise of this Warrant immediately prior to such subdivision or to the issuance of such stock dividend shall be proportionately increased, and the Exercise Price shall be proportionately decreased, and in the event that the Company shall at any time combine the outstanding shares of Common Stock, the number of Warrant Shares issuable upon exercise of this Warrant immediately prior to such combination shall be proportionately decreased, and the Exercise Price shall be proportionately increased, effective at the close of business on the date
of such subdivision, stock dividend or combination, as the case may be.

	
            (c)
 	
            Adjustment Upon Issuance of Shares of Common Stock Below Exercise Price.
 

(i)          If the Company, at any time or from time to time, issues or sells any Additional Shares of Common Stock (as defined below), other than as provided in the foregoing subsections of this Section 3, for a price per share (the “Per Share Price”) (which, in the case of options, warrants, convertible securities or other rights, includes the amounts paid therefor plus the exercise price, conversion price or other such amounts payable thereunder) that is less than the then applicable Exercise Price, then and in each such case, the then applicable Exercise Price shall automatically be reduced as of the opening of business on the date of such issue or sale, to the Per Share Price.  “Additional Shares of Common
Stock” shall mean all shares of Common Stock, and all options, warrants, convertible securities or other rights to purchase or acquire shares of Common Stock, issued by the Company other than (A) shares of Common Stock and/or options, warrants or other Common Stock purchase rights, where such options, warrants or other rights are issued both (i) with exercise prices per share of Common Stock at the then-current fair market value of a share of Common Stock, as determined in good faith by the Board of Directors of the Company, and (ii) to employees, officers or directors of, or consultants to, the Company or any subsidiary pursuant to stock purchase or stock option plans or other arrangements that are approved by the Company’s Board of Directors and (B) shares of Common Stock issued 

 

3

 

 

pursuant to the exercise of options, warrants or convertible securities outstanding as of the date hereof. 

(ii)        In the event that the exercise price, conversion price, purchase price or other price at which shares of Common Stock are purchasable pursuant to any options, warrants, convertible securities or other rights to purchase or acquire Common Stock is reduced at any time or from time to time (other than under or by reason of provisions designed to protect against dilution), then, upon such reduction becoming effective, the Exercise Price then in effect hereunder shall forthwith be decreased to such Exercise Price as would have been obtained had the adjustments made and required under this Section 3 upon the issuance of such options, warrants, convertible securities or other rights been made upon the basis of (and the total consideration received therefor) (A) the issuance of the number of shares of Common Stock
theretofore actually delivered upon the exercise, conversion or exchange of such options, warrants, convertible securities or other rights, (B) the issuance of all of the Common Stock and all other options, warrants, convertible securities and other rights to purchase or acquire Common Stock issued after the issuance of the modified options, warrants, convertible securities or other rights, and (C) the original issuance at the time of the reduction of any such options, warrants, convertible securities or other rights then still outstanding.

(iii)       In no event shall an adjustment under this Section 3(c) be made if it would result in an increase in the then applicable Exercise Price.

(iv)        The provisions of this Section 3(c) shall terminate and be of no further force or effect on         , 2007.

(d)         Notice of Corporate Action. If at any time (i) the Company shall take a record of the holders of its Common Stock for the purpose of entitling them to receive a dividend (other than a cash dividend payable out of earnings or earned surplus legally available for the payment of dividends under the laws of State of Nevada) or other distribution, or any right to subscribe for or purchase any evidences of its indebtedness, any shares of stock of any class or any other securities or property, or to receive any other right; (ii) there shall be any capital reorganization of the Company, any reclassification or recapitalization of the capital stock of the Company or any consolidation or merger of the Company with, or any sale, transfer or other disposition of all or substantially all the property, assets
or business of the Company to, another corporation; or (iii) there shall be a voluntary or involuntary dissolution, liquidation or winding up of the Company, then, in any one or more of such cases, the Company shall give to the Holder (i) at least 10 business days prior written notice of the date on which a record date shall be selected for such dividend, distribution or right or for determining rights to vote in respect of any such reorganization, reclassification, merger, consolidation, sale, transfer, disposition, dissolution, liquidation or winding up, and (ii) in the case of any such reorganization, reclassification, merger, consolidation, sale, transfer, disposition, dissolution, liquidation or winding up, at least 10 business days prior written notice of the date when the same shall take place. Such notice in accordance with the foregoing clause also shall specify (i) the date on which any such record is to be taken for the purpose of such dividend, distribution or right, the
date on which the holders 

 

4

 

 

of Common Stock shall be entitled to any such dividend, distribution or right, and the amount and character thereof, and (ii) the date on which any such reorganization, reclassification, merger, consolidation, sale, transfer, disposition, dissolution, liquidation or winding up is to take place and the time, if any such time is to be fixed, as of which the holders of Common Stock shall be entitled to exchange their shares of Common Stock for securities or other property deliverable upon such reorganization, reclassification, merger, consolidation, sale, transfer, disposition, dissolution, liquidation or winding up. Each such written notice shall be sufficiently given if addressed to the Holder at the last address of the Holder appearing on the books of the Company and delivered in accordance with Section 11(d).

	
            4.
 	
            Transfer of Warrant and Resale of Warrant Shares.  
 

(a)         This Warrant may only be transferred in compliance with federal and state securities laws.

(b)         At the time of the surrender of this Warrant in connection with any transfer of this Warrant or the resale of the Warrant Shares, the Company may require, as a condition of allowing such transfer (i) that the Holder or transferee of this Warrant or the Warrant Shares as the case may be, furnish to the Company a written opinion of counsel that is reasonably acceptable to the Company to the effect that such transfer may be made without registration under the Securities Act or qualification under any state securities laws, (ii) that the Holder or transferee execute and deliver to the Company an investment representation letter in form and substance acceptable to the Company containing among other provisions representations and warranties similar to those set forth in Section 5 and (iii) that the transferee be an
“accredited investor” as defined in Rule 501(a) promulgated under the Securities Act. Transfer of this Warrant and all rights hereunder, in whole or in part, in accordance with the foregoing provisions, shall be registered on the books of the Company to be maintained for such purpose, upon surrender of this Warrant at the principal office of the Company or the office or agency designated by the Company, together with a written assignment of this Warrant substantially in the form of Exhibit C hereto duly executed by the Holder or its attorney-in-fact and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees and in the denomination specified in such instrument of assignment, and shall issue to the Holder a new warrant evidencing the portion of
this Warrant not so assigned, and this Warrant shall be deemed cancelled.  This Section 4 shall survive the exercise or expiration of the Warrant.

	
            5.
 	
            Representations and Warranties of Holder.
 

(a)         Exempt Transaction; Restricted Securities.  The Holder understands that this Warrant is being offered and sold in reliance on one or more exemptions from registration provided for under the Securities Act, and that the Company’s reliance upon such exemptions is predicated, in part, upon the Holder’s representations and warranties set forth in this Warrant.  The Holder understands that this Warrant and the Warrant Shares are “restricted securities” as such term is defined in Rule 144 promulgated under the Securities Act (“Rule 144”).  The Holder understands that the Holder may resell the Warrant Shares pursuant to Rule 144 only after the 

 

5

 

 

satisfaction of certain requirements, including the requirement that the Warrant Shares be held for at least one year prior to resale.

(b)         Investment Intent; Accreditation; Authority.  The Holder is acquiring this Warrant for investment for the Holder’s own account, not as nominee or agent, for investment and not with a view to, or for resale in connection with, any distribution or public offering thereof within the meaning of the Securities Act.  The Holder is an “accredited investor” within the meaning of the Securities Act.  The Holder has the full right, power, authority and capacity to enter into and perform this Warrant and the terms of this Warrant constitute valid and binding obligations of the Holder enforceable in accordance with its terms, except as the same may be limited by equitable principles and by bankruptcy, insolvency, moratorium, and other laws of general application affecting the enforcement of
creditors’ rights.

(c)         Knowledge and Experience.  The Holder has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of the Holder’s investment in this Warrant and has the ability to bear the economic risks of such investment.

(d)         Domicile.  The Holder is a bona fide resident and domiciliary (not a temporary or transient resident) of the jurisdiction indicated on the signature page to this Warrant and the Holder has no present intention of becoming a resident of any other state or jurisdiction.

	
            6.
 	
            Conditions to Exercise of Warrant.  
 

(a)         Each certificate evidencing the Warrant Shares issued upon exercise of this Warrant shall be stamped or imprinted with a legend substantially in the following form:

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE ACT OR, IN THE OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE WITH AN EXEMPTION THEREWITH.

(b)         Removal of Legend and Transfer Restrictions.  Any legend endorsed on a certificate pursuant to this Section 6 shall be removed, and the Company shall issue a certificate without such legend to the holder of such Warrant Shares if (i) such Warrant Shares are resold pursuant to a registration statement under the Securities Act and a prospectus meeting the requirements of Section 11 of the Securities Act is delivered or deemed delivered to the purchaser of such Warrant Shares, (ii) if such holder satisfies the requirements of Rule 144(k) under the Securities Act or (iii) if such holder provides the Company with an opinion of counsel for such holder of the Warrant Shares, reasonably satisfactory to the Company, to the effect that a sale, transfer or assignment of such Warrant
Shares may be made without registration and that upon such sale, transfer or assignment such Warrant Shares will not be deemed “restricted securities,” as such term is defined in Rule 144 under the Securities Act.

 

6

 

 

7.           Fractional Shares.  No fractional Warrant Shares will be issued in connection with any exercise of this Warrant, but in lieu of such fractional shares the Company shall make a cash payment therefor upon the basis of the Exercise Price then in effect.

8.           No Rights of Stockholders.  The Holder shall not be entitled to vote or receive dividends or be deemed the holder of Warrant Shares or any other securities of the Company which may at any time be issuable on the exercise of this Warrant for any purpose, nor shall anything contained herein be construed to confer upon the Holder any of the rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action (whether upon any recapitalization, issuance of stock, reclassification of stock, change of par value, consolidation, merger, conveyance, or otherwise) or to receive dividends or subscription rights or otherwise with respect to the Warrant
Shares until this Warrant shall have been exercised and the Warrant Shares purchasable upon the exercise of this Warrant shall have become deliverable, as provided in this Warrant.

9.           Registration Rights.  The Holder shall have the registration rights set forth in Section 8 of the Securities Purchase Agreement, dated as of the date hereof (the “Purchase Agreement”), between the Company and the Holder.

10.         Term of Warrant.  This Warrant shall become exercisable on the Warrant Date and shall no longer be exercisable as of the earlier of (i) 5:00 p.m., Eastern time, on         , 2009; and (ii) immediately prior to the consummation of a Change of Control.

	
            11.
 	
            Miscellaneous.
 

(a)         This Warrant shall be construed and enforced in accordance with and governed by the laws of the State of New York, without giving effect to principles of conflicts of laws. 

(b)         The headings in this Warrant are for purposes of reference only, and shall not limit or otherwise affect any of the terms of this Warrant.

(c)         The terms of this Warrant shall be binding upon and shall inure to the benefit of any successors or assigns of the Company and of the Holder and of the Warrant Shares issued or issuable upon the exercise of this Warrant.

(d)         Any notice provided for or permitted under this Warrant shall be given in accordance with the terms of Section 9(d) of the Purchase Agreement.

(e)         This Warrant constitutes the full and entire understanding and agreement between the parties with regard to the subject of this Warrant.

(f)          Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of any such loss, theft or destruction, upon delivery of an indemnity agreement reasonably satisfactory in form and amount to the Company or, in the case of any such mutilation, upon surrender and cancellation of such Warrant, the Company at the Holder’s expense will execute and deliver to the holder of record, in lieu thereof, a new Warrant of like date and tenor.

 

7

 

 

(g)         This Warrant and any provision of this Warrant may be amended, waived or terminated only by an instrument in writing signed by the Company and the Holder.

[Remainder of page intentionally left blank]

 

8

 

 

 

IN WITNESS WHEREOF, the Company has executed this Warrant as of the Warrant Date.

PROTOCALL TECHNOLOGIES INCORPORATED

By:                                           
                        

	
             
 	
            Chief Executive Officer
 

 

SIGNATURE PAGE TO WARRANT TO PURCHASE COMMON STOCK

 

 

 

EXHIBIT A

 

Notice of Exercise

	
            TO:
 	
            Protocall Technologies Incorporated
 

1.           The undersigned hereby elects to purchase ______________ Warrant Shares pursuant to the terms of Section 1(b) of the Warrant to Purchase Common Stock dated, _________ 2006 (the “Warrant”), issued by Protocall Technologies Incorporated (the “Company”), and tenders herewith payment of the aggregate Exercise Price of such Warrant Shares in full.

2.            Please issue a certificate or certificates representing said Warrant Shares in the name of the undersigned or in such other name as is specified below:

	
             
 	
            Name:
 	
            _________________________________
 

 

	
             
 	
            Address:
 	
            _________________________________
 

_________________________________

3.            ____________________ hereby represents and warrants that the aforesaid shares of Common Stock are being acquired for the account of the undersigned for investment and not with a view to, or for resale, in connection with the distribution thereof, and that the undersigned has no present intention of distributing or reselling such shares, and that all representations and warranties of the undersigned set forth in Section 5 of the Warrant were true and correct as of the Warrant Date (as defined in the Warrant) and are true and correct as of the date hereof.

_____________________________________

Name: 

	
             
 	
            Date:
 	
            _______________________________
 

 

 

 

 

EXHIBIT B

 

Notice of Cashless Exercise

	
            TO:
 	
            Protocall Technologies Incorporated
 

1.           The undersigned hereby elects to exchange its Warrants for ______________ Warrant Shares pursuant to the terms of Section 1(b) of the Warrant to Purchase Common Stock dated, __________2006 (the “Warrant”), issued by Protocall Technologies Incorporated (the “Company”).

2.            Please issue a certificate or certificates representing said Warrant Shares in the name of the undersigned or in such other name as is specified below:

	
             
 	
            Name:
 	
            _________________________________
 

 

	
             
 	
            Address:
 	
            _________________________________
 

_________________________________

3.            ____________________ hereby represents and warrants that the aforesaid shares of Common Stock are being acquired for the account of the undersigned for investment and not with a view to, or for resale, in connection with the distribution thereof, and that the undersigned has no present intention of distributing or reselling such shares, and that all representations and warranties of the undersigned set forth in Section 5 of the Warrant were true and correct as of the Warrant Date (as defined in the Warrant) and are true and correct as of the date hereof.

_____________________________________

Name: 

	
             
 	
            Date:
 	
            _______________________________
 

 

 

 

 

EXHIBIT C

 

Assignment Form

FOR VALUE RECEIVED, _________________________ (the “Holder”), party to the Warrant to Purchase Common Stock, dated _____________, 2006 (the “Warrant”), with Protocall Technologies Incorporated (the “Company”), hereby sells, assigns and transfers unto the assignee named below all of the rights of the Holder under the Warrant, with respect to the number of shares of Common Stock set forth below:

_______________________________________

_______________________________________

_______________________________________

(Name and Address of Assignee)

_______________________________________

(Number of Shares of Common Stock)

and does hereby irrevocably constitute and appoint ____________ attorney-in-fact to register such transfer on the books of the Company, maintained for the purpose, with full power of substitution in the premises. 

Dated:_________________________________

______________________________________

(Print Name and Title)

______________________________________

(Signature) 

______________________________________

(Witness)

NOTICE: The signature on this assignment must correspond with the name as written upon the face of the Warrant in every particular, without alteration or enlargement or any change whatsoever.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}]]